CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-01 | Korbel Gregory Alan SVP, Chief Business Officer | Option exercise · Stock Option (right to Buy) | −27,500 | 25,245 | ||
| 2021-09-20 | Korbel Gregory Alan SVP, Chief Business Officer | Sale | −5,460 | $4.98 | $27K | 17,167 |
| 2021-09-20 | Korbel Gregory Alan SVP, Chief Business Officer | Option exercise | +27,500 | $0.92 | $25K | 44,667 |
| 2021-09-20 | Korbel Gregory Alan SVP, Chief Business Officer | Sale | −27,500 | $4.97 | $137K | 17,167 |
| 2021-09-20 | Korbel Gregory Alan SVP, Chief Business Officer | Option exercise · Stock Option (right to Buy) | −27,500 | 52,745 | ||
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Option exercise | +25,000 | $0.92 | $23K | 44,000 |
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Sale | −25,000 | $4.97 | $124K | 19,000 |
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Option exercise · Stock Option (right to Buy) | −25,000 | 80,587 | ||
| 2021-09-16 | Attar Eyal C. SVP, Chief Medical Officer | Sale | −15,968 | $4.68 | $75K | 83,000 |
| 2021-09-10 | Korbel Gregory Alan Chief Business Officer | Shares withheld for taxes | −1,724 | $4.59 | $8K | 22,627 |
| 2021-08-25 | Korbel Gregory Alan Chief Business Officer | Shares withheld for taxes | −1,149 | $3.98 | $5K | 24,351 |
| 2021-08-25 | Coiante Scott M SVP, Chief Financial Officer | Shares withheld for taxes | −7,534 | $3.98 | $30K | 91,466 |
| 2021-08-25 | Attar Eyal C. SVP, Chief Medical Officer | Shares withheld for taxes | −9,032 | $3.98 | $36K | 98,968 |
| 2021-06-30 | HENNEMAN JOHN B III Director | Grant or award | +4,610 | 9,610 | ||
| 2021-06-30 | HENNEMAN JOHN B III Director | Grant or award · Stock Option (Right to Buy) | +22,750 | 22,750 | ||
| 2021-06-30 | Kelly Michael Aaron Director | Grant or award | +4,610 | 4,610 | ||
| 2021-06-30 | Kelly Michael Aaron Director | Grant or award · Stock Option (Right to Buy) | +22,750 | 22,750 |
Page 10 of 10 · 197 trades